None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All adults 18 years and older with a clinical diagnosis of AN affecting the face, neck, or elbow, or any combination of these three, who presented to the dermatology outpatient department and are willing to give consent
Exclusion criteria
Exclusion criteria: Pregnant and lactating females. Hypersensitivity to the peeling agent. Skin infection at the site of AN (herpes, pyoderma, and folliculitis). Individuals prone to keloid formation. History of any topical application in the last 4 weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in severity of acanthosis nigricans as assessed by Acanthosis Nigricans Severity Index (ANSI) scoreTimepoint: At baseline, 2,4,6 and 8 weeks after initiation of treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient satisfaction assessed by Visual Analogue Scale (VAS).Timepoint: At 12 weeks. | — |
Countries
India
Contacts
JJM Medical College